Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kojiro Ohba

Showing results (111-120 of 131) with videos related to

Pageof 14
Sort By:
Glycoconjugate Journal|June 28, 2019
Stage-specific embryonic antigen-4 is a histological marker reflecting the malignant behavior of prostate cancerYuichiro Nakamura, Yasuyoshi Miyata, Tomohiro Matsuo, et al.
BJU International|August 12, 2021
Intravesical mitomycin C (MMC) and MMC + cytosine arabinoside for non-muscle-invasive bladder cancer: a randomised clinical trialYasuyoshi Miyata, Toshifumi Tsurusaki, Yasushi Hayashida, et al.
Clinical Genitourinary Cancer|April 30, 2025
Efficacy of Neoadjuvant Hormonal Therapy for High-Risk Prostate Cancer Undergoing Robot-Assisted Radical Prostatectomy: A Retrospective Multicenter Study Using Propensity Score-Matched Analysis in JapanMinori Nezasa, Makoto Kawase, Satoshi Washino, et al.
Scientific Reports|October 14, 2021
Oral administration of E-type prostanoid (EP) 1 receptor antagonist suppresses carcinogenesis and development of prostate cancer via upregulation of apoptosis in an animal modelMasahito Masato, Yasuyoshi Miyata, Hiroki Kurata, et al.
International Journal of Clinical Oncology|December 19, 2022
Prognostic value of PD-L1 expression in recurrent renal cell carcinoma after nephrectomy: a secondary analysis of the ARCHERY studySatoshi Tamada, Masahiro Nozawa, Kojiro Ohba, et al.
Hinyokika Kiyo. Acta Urologica Japonica|March 2, 2023
[A Retrospective Study on the Malignancies after Renal Transplantation]Tsuyoshi Matsuda, Yasushi Mochizuki, Yuta Mukae, et al.
Journal of Bone and Mineral Metabolism|August 16, 2019
Epidemiological survey and risk factor analysis of dialysis-related amyloidosis including destructive spondyloarthropathy, dialysis amyloid arthropathy, and carpal tunnel syndromeAtsushi Tagami, Masato Tomita, Shinji Adachi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|November 26, 2025
Outcomes of Nivolumab-Plus-Ipilimumab in Metastatic Renal Cell Carcinoma: Second Interim Analysis of the J-ENCORE StudyTomokazu Sazuka, Katsunori Tatsugami, Suguru Shirotake, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 17, 2026
A Minimum 3-Year Follow-Up of Nivolumab-Plus-Ipilimumab in Japanese Patients With Advanced or Metastatic Renal Cell Carcinoma: A Final Analysis of the J-ENCORE StudyShuzo Hamamoto, Masahiro Nozawa, Suguru Shirotake, et al.
Pediatric Surgery International|June 26, 2026
Late metachronous contralateral torsion after testicular torsion without contralateral orchiopexy: a mid- to long-term follow-up studyJunki Harada, Kensuke Mitsunari, Shota Kakita, et al.
Pageof 14

Showing results (111-120 of 131) with videos related to

Sort By:
Pageof 14
Glycoconjugate Journal|June 28, 2019
Stage-specific embryonic antigen-4 is a histological marker reflecting the malignant behavior of prostate cancerYuichiro Nakamura, Yasuyoshi Miyata, Tomohiro Matsuo, et al.
BJU International|August 12, 2021
Intravesical mitomycin C (MMC) and MMC + cytosine arabinoside for non-muscle-invasive bladder cancer: a randomised clinical trialYasuyoshi Miyata, Toshifumi Tsurusaki, Yasushi Hayashida, et al.
Clinical Genitourinary Cancer|April 30, 2025
Efficacy of Neoadjuvant Hormonal Therapy for High-Risk Prostate Cancer Undergoing Robot-Assisted Radical Prostatectomy: A Retrospective Multicenter Study Using Propensity Score-Matched Analysis in JapanMinori Nezasa, Makoto Kawase, Satoshi Washino, et al.
Scientific Reports|October 14, 2021
Oral administration of E-type prostanoid (EP) 1 receptor antagonist suppresses carcinogenesis and development of prostate cancer via upregulation of apoptosis in an animal modelMasahito Masato, Yasuyoshi Miyata, Hiroki Kurata, et al.
International Journal of Clinical Oncology|December 19, 2022
Prognostic value of PD-L1 expression in recurrent renal cell carcinoma after nephrectomy: a secondary analysis of the ARCHERY studySatoshi Tamada, Masahiro Nozawa, Kojiro Ohba, et al.
Hinyokika Kiyo. Acta Urologica Japonica|March 2, 2023
[A Retrospective Study on the Malignancies after Renal Transplantation]Tsuyoshi Matsuda, Yasushi Mochizuki, Yuta Mukae, et al.
Journal of Bone and Mineral Metabolism|August 16, 2019
Epidemiological survey and risk factor analysis of dialysis-related amyloidosis including destructive spondyloarthropathy, dialysis amyloid arthropathy, and carpal tunnel syndromeAtsushi Tagami, Masato Tomita, Shinji Adachi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|November 26, 2025
Outcomes of Nivolumab-Plus-Ipilimumab in Metastatic Renal Cell Carcinoma: Second Interim Analysis of the J-ENCORE StudyTomokazu Sazuka, Katsunori Tatsugami, Suguru Shirotake, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 17, 2026
A Minimum 3-Year Follow-Up of Nivolumab-Plus-Ipilimumab in Japanese Patients With Advanced or Metastatic Renal Cell Carcinoma: A Final Analysis of the J-ENCORE StudyShuzo Hamamoto, Masahiro Nozawa, Suguru Shirotake, et al.
Pediatric Surgery International|June 26, 2026
Late metachronous contralateral torsion after testicular torsion without contralateral orchiopexy: a mid- to long-term follow-up studyJunki Harada, Kensuke Mitsunari, Shota Kakita, et al.
Pageof 14